Dyslipidemias is a group of asymptomatic disorders identifiable by the presence of abnormal concentrations of cholesterol, triglycerides, and HDL cholesterol caused by an abnormal composition and/or number of plasma lipoproteins. They are a major risk factor for having atherosclerotic cardiovascular disease; its treatment has been highly effective to reduce cardiovascular mortality (Catapano et al. 2016).
Lipoproteins are complex structures that transport lipids in their interior to make it soluble in the aqueous media of plasma (Durrington 2003). Lipid transport has two destinations. The first route transports lipids from the sites of production or absorption (intestine and liver) to the tissues where they are used or stored (muscle, fat, glands, etc.). In the case of the liver, the lipoprotein synthesis takes 8–12 h and it is highly regulated by insulin and the fatty...
- Bello-Chavolla OY, Kuri-García A, Ríos-Ríos M, Vargas-Vázquez A, Cortés-Arroyo JE, Tapia-González G, Cruz-Bautista I, Aguilar-Salinas CA (2018) Familial combined hyperlipidemia: current knowledge, perspectives and controversies. Rev Invest Clin 70(5):224–236. https://doi.org/10.24875/RIC.1800257CrossRefGoogle Scholar
- Catapano A et al (2016) ESC/EAS guidelines for the management of dyslipidaemias. The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 37:2999–3058. https://doi.org/10.1093/eurheartj/ehw272.CrossRefGoogle Scholar
- Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Monique Verschuren WM, Vlachopoulos C, Wood DA, Luis Zamorano J, Cooney MT (2016) ESC/EAS guidelines for the management of dyslipidaemias. Atherosclerosis 252:207–274Google Scholar
- Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J (2018) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation 10:CIR0000000000000625. https://doi.org/10.1161/CIR.0000000000000625CrossRefGoogle Scholar